|
TOP1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.03139999999102E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.89170000000727E-06 |
| Normal-vs-Stage2 |
3.595600E-02 |
| Normal-vs-Stage3 |
9.940400E-02 |
| Normal-vs-Stage4 |
1.528060E-02 |
| Stage1-vs-Stage2 |
7.134600E-01 |
| Stage1-vs-Stage3 |
1.900000E-01 |
| Stage1-vs-Stage4 |
6.927200E-01 |
| Stage2-vs-Stage3 |
5.461400E-01 |
| Stage2-vs-Stage4 |
9.216200E-01 |
| Stage3-vs-Stage4 |
6.647800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.4028999999981E-05 |
| Normal-vs-AfricanAmerican |
5.791600E-04 |
| Normal-vs-Asian |
2.417700E-02 |
| Caucasian-vs-AfricanAmerican |
9.545000E-01 |
| Caucasian-vs-Asian |
8.591400E-01 |
| AfricanAmerican-vs-Asian |
8.718600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.44340000022225E-07 |
| Normal-vs-Female |
1.040830E-01 |
| Male-vs-Female |
2.595100E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.386090E-04 |
| Normal-vs-Extreme_Weight |
2.70999999996135E-07 |
| Normal-vs-Obese |
3.702000E-02 |
| Normal-vs-Extreme_Obese |
4.697800E-02 |
| Normal_Weight-vs-Extreme_Weight |
7.595800E-01 |
| Normal_Weight-vs-Obese |
4.795700E-02 |
| Normal_Weight-vs-Extreme_Obese |
9.701200E-01 |
| Extreme_Weight-vs-Obese |
5.701000E-03 |
| Extreme_Weight-vs-Extreme_Obese |
8.251000E-01 |
| Obese-vs-Extreme_Obese |
2.573800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.462800E-01 |
| Normal-vs-Age(41-60Yrs) |
6.078200E-03 |
| Normal-vs-Age(61-80Yrs) |
3.59319999976293E-07 |
| Normal-vs-Age(81-100Yrs) |
1.65419999997862E-06 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.671800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.680500E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.801500E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.944200E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.261200E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.184390E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.99710000003961E-06 |
| Normal-VS-Type2 PRCC |
6.22430000000174E-05 |
| Normal-VS-KIRP CIMP |
9.207000E-01 |
| Normal-VS-Unclassified PRCC |
3.636000E-01 |
| Type1 PRCC-VS-Type2 PRCC |
9.388200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
4.682000E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
1.814390E-02 |
| Type2 PRCC-VS-KIRP CIMP |
6.202200E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
4.051900E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
6.738600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.01520000004041E-06 |
| Normal-vs-N1 |
7.713600E-01 |
| Normal-vs-N2 |
2.234400E-01 |
| N0-vs-N1 |
2.477800E-03 |
| N0-vs-N2 |
3.824400E-01 |
| N1-vs-N2 |
5.321200E-01 |
|
|
